Pharmaceutical giant Pfizer is already taking steps to begin testing its novel coronavirus vaccine on patients as young as 12.
Dr. Robert Frenck, director of the Vaccine Research Center at Cincinnati Children’s Hospital, told CNN on Tuesday that parents have already expressed an interest in enrolling their children in the study.
Experimental vaccinations of teenagers aged 16 and 17 in the study are slated to begin this week with children ages 12 to 15 to be enrolled at a later date, WLNY reported.
Frenck also noted this will be the first COVID-19 clinical trial in the United States to include children, and the company noted on its website that the U.S. Food and Drug Administration has granted approval to include children as young as 12 in the study, CNN reported.
“We really think a vaccine for adolescents and children is going to be critical for getting (COVID-19) under control,” Frenck told CNN in a telephone interview.
“I think one of the things that is important to remember is that although the death rate for children with (COVID-19) is lower than in older adults, it’s not zero,” he said, noting that more than half a million children have been diagnosed to date with coronavirus in the United States.
Read more here.
More coronavirus pandemic coverage:
© 2020 Cox Media Group